ClinicalTrials.Veeva

Menu

Deep Learning Radiomics Model for Predicting Post-cystectomy Outcome in Muscle Invasive Bladder Cancer

C

Chongqing Medical University

Status

Enrolling

Conditions

Bladder Cancer

Treatments

Other: develop and validate a deep learning radiomics model based on preoperative enhanced CT image

Study type

Observational

Funder types

Other

Identifiers

NCT06092450
2022-K508 (Other Identifier)
AI-BLCA

Details and patient eligibility

About

Muscle invasive bladder cancer (MIBC) has a poor prognosis even after radical cystectomy. Postoperative survival stratification based on radiomics and deep learning may be useful for treatment decisions to improve prognosis. This study was aimed to develop and validate a deep learning radiomics model based on preoperative enhanced CT to predict postoperative survival in MIBC.

Enrollment

500 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients with pathologically confirmed MIBC after radical cystectomy;
  • contrast-CT scan less than two weeks before surgery;
  • complete CT image data and clinical data.

Exclusion criteria

  • patients who received neoadjuvant therapy;
  • non-urothelial carcinoma;
  • poor quality of CT images;
  • incomplete clinical and follow-up data.

Trial design

500 participants in 1 patient group

MIBC
Description:
patients with pathologically confirmed MIBC after radical cystectomy
Treatment:
Other: develop and validate a deep learning radiomics model based on preoperative enhanced CT image

Trial contacts and locations

1

Loading...

Central trial contact

Zongjie Wei

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems